Top 5 Most Read RNS's on Vox Markets for Monday 16th January 2023

Episode 1124,  Jan 16, 07:55 AM

Top 5 Most Read RNS's on Vox Markets for Monday 16th January 2023

5. ITM Power #ITM - Trading & Operational Update

Whilst the process is ongoing, it has become clear that the outcome for the financial year ending 30 April 2023 will be materially different from the current guidance, with lower revenue and a higher EBITDA loss.

Our balance sheet remains in a strong position with net cash as at 30 October 2022 of £318m.

4. Helium One Global #HE1 - Notice of Annual General Meeting

Helium One Global confirms that the Company's Annual General Meeting will be held at 3:00 p.m. GMT on 15 February 2023 at the offices of Hill Dickinson LLP at 8th Floor, The Broadgate Tower, 20 Primrose Street, London, EC2A 2EW.

3. Amigo Holdings #AMGO - Scheme of arrangement update

To-date it has been unable to secure a commitment from a cornerstone investor to underwrite the whole of the Capital Raise. A number of investors have expressed possible interest in making a minority investment. Amigo is therefore assessing whether there is sufficient interest for a syndicate of such investors to be formed in order to support a £45m Capital Raise.

2. Clontarf Energy #CLON - £1.3 million Fundraising and Corporate Update

Clontarf Energy announce that the Company has raised £1,300,000 via a placing at a price of 0.065p per Share

1. Poolbeg Pharma #POLB - Strategic expansion of POLB 001 into oncology

Newly filed patent application to protect use of POLB 001 for new oncology indication

· Scientific findings indicate POLB 001 has the potential to dampen the pro-inflammatory cytokine release syndrome affecting patients receiving CAR T cell therapies

· Patent application covers a method of use of all p38 inhibitors during CAR T cell therapy

· Progressing towards trial initiation in CAR T cell patients in 2024